Functional recovery in a Friedreich's ataxia mouse model by frataxin gene transfer using an HSV-1 amplicon vector.
about
Effects of intravenous administration of human umbilical cord blood stem cells in 3-acetylpyridine-lesioned ratsMitochondrial hexokinase II promotes neuronal survival and acts downstream of glycogen synthase kinase-3.Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.Mutations in the substrate binding glycine-rich loop of the mitochondrial processing peptidase-α protein (PMPCA) cause a severe mitochondrial disease.Gene Transfer of Brain-derived Neurotrophic Factor (BDNF) Prevents Neurodegeneration Triggered by FXN DeficiencyRationale for the development of 2-aminobenzamide histone deacetylase inhibitors as therapeutics for Friedreich ataxia.Current and emerging treatment options in the management of Friedreich ataxia.Infectious delivery and long-term persistence of transgene expression in the brain by a 135-kb iBAC-FXN genomic DNA expression vector.Utilization of Site-Specific Recombination in Biopharmaceutical Production.Therapeutic approaches for the treatment of Friedreich's ataxia.Pharmacological therapeutics in Friedreich ataxia: the present state.Herpes Virus Amplicon Vectors.Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy.Sustained FXN expression in dorsal root ganglia from a nonreplicative genomic HSV-1 vector.Neurobehavioral deficits in the KIKO mouse model of Friedreich's ataxia.Transplantation of wild-type mouse hematopoietic stem and progenitor cells ameliorates deficits in a mouse model of Friedreich's ataxia.FXN methylation predicts expression and clinical outcome in Friedreich ataxia.HSV-1 as a Model for Emerging Gene Delivery Vehicles
P2860
Q28390509-6FAB9CE9-BBF4-48DA-B90E-5308F591DE39Q34888702-BDED685C-845C-452B-B59F-929E22D83997Q34989407-B85F4B16-3172-4523-A11A-0165D9C298C0Q36859413-B67BD992-427B-4821-9D5C-F8A4BB08A13DQ36939767-FE1C89AC-A3A5-43A3-A488-311880E92468Q37095593-26B2E730-C3EE-47B4-A4F7-7B7F8D07CF65Q37790615-5B7F2117-792E-4C14-8DE1-E66288756F3CQ38335921-91E23302-8CCE-4970-84A7-3EC75F524531Q38646228-B6589372-F5B0-4980-947D-013126D1DAA1Q39158402-760C9E3C-E5F9-4D2C-8B44-2B586BAADDAFQ39445743-B08562FC-B7F3-43F5-8EEE-A10A50E85F90Q39923388-0023E70C-B07C-48C7-9679-FD1447CD2FB7Q41982319-E5705CD2-10CE-4869-BBC0-6473BE2E237CQ45873314-5665FA26-E5A5-4ECE-8240-E57F8978CB3EQ45956921-CB566618-2DE5-4324-B29D-392D7A5E497FQ46169576-8F10497E-8BFF-4BEB-B3AE-901A2D99B782Q47872898-9AFCF685-D18E-438D-8838-B16F9472907BQ58995392-764197F0-9938-479D-9D89-832FEC7C87C0
P2860
Functional recovery in a Friedreich's ataxia mouse model by frataxin gene transfer using an HSV-1 amplicon vector.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Functional recovery in a Fried ...... sing an HSV-1 amplicon vector.
@ast
Functional recovery in a Fried ...... sing an HSV-1 amplicon vector.
@en
Functional recovery in a Fried ...... sing an HSV-1 amplicon vector.
@nl
type
label
Functional recovery in a Fried ...... sing an HSV-1 amplicon vector.
@ast
Functional recovery in a Fried ...... sing an HSV-1 amplicon vector.
@en
Functional recovery in a Fried ...... sing an HSV-1 amplicon vector.
@nl
prefLabel
Functional recovery in a Fried ...... sing an HSV-1 amplicon vector.
@ast
Functional recovery in a Fried ...... sing an HSV-1 amplicon vector.
@en
Functional recovery in a Fried ...... sing an HSV-1 amplicon vector.
@nl
P2093
P50
P356
P1433
P1476
Functional recovery in a Fried ...... sing an HSV-1 amplicon vector.
@en
P2093
Alfredo Giménez-Cassina
Belen Illana
Christina Mauritz
Gloria M Palomo
Javier Díaz-Nido
P304
P356
10.1038/SJ.MT.6300143
P577
2007-03-20T00:00:00Z